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The crystal structure of Seneca Valley Virus-001
(SVV-001), the representative member of a new ge-
nus, Senecavirus, is reported at 2.3A˚ resolution.
SVV-001 is the first naturally occurring nonpatho-
genic picornavirus shown to mediate selective cyto-
toxicity towards tumor cells with neuroendocrine
cancer features. The nonsegmented (+) ssRNA ge-
nome of SVV-001 shares closest sequence similarity
with the genomes of the members of Cardiovirus.
The overall tertiary structure of VP1-VP4 subunits is
conserved with the exception of loops, especially
those of VP1 that show large deviations relative to
the members of the cardioviruses. The surface loops
of VP1 and VP2 are predicted to mediate cell tropism
of SVV-001. In addition, the organization of the pack-
aged nucleic acid density indicates that certain re-
gions of VP2 and VP4 interact closely with the pack-
aged nucleic acid.
INTRODUCTION
Viruses have been used in the treatment of cancer from as early
as the 1940s, with the first human clinical trial dating back to
1956 for the treatment of cervical cancer (Huebner et al.,
1956). Among the new virotherapies, use of viruses that specifi-
cally infect cancer cells is in the forefront (Lin and Nemunaitis,
2004). These include CAV21 (Au et al., 2005), developed by Viro-
lytics under the name of CAVATAK; Reovirus (Thirukkumaran
et al., 2003)-based REOLYSIN, developed by Oncolytics Bio-
tech, Inc.; Newcastle disease virus (Fiola et al., 2006), developed
by Theravir Management Ltd.; Vesicular stomatitis virus (Diaz
et al., 2007), developed by Onco Therapy Science; and the mea-
sles virus (Yanagi et al., 2006). A newmember to join this group is
the Seneca Valley Virus-001 (SVV-001).
SVV-001 is the first member of a new genus called Senecavi-
rus in the family of Picornaviridae that is proposed to include
other porcine picornaviruses that share similarity in sequence
and biochemical properties with SVV-001 (Hales et al., 2008;
Reddy et al., 2007). SVV-001 was serendipitously discovered
as a contaminant during cultivation of PER.C6 cells, transformed
fetal retinoblast cells (Fallaux et al., 1998; Reddy et al., 2007), and
is presumed to be introduced via bovine serum or porcine trypsinStructure 16, 1555–source. SVV-001 shows closest sequence similarity to cardiovi-
ruses among other known picornaviruses and has an infectious
RNA genome (GenBank accession number DQ641257) of 7310
bases that codes for four capsid proteins and seven other non-
structural proteins. There are long and short UTRs at the 50
and 30 ends of the genome, respectively (Hales et al., 2008).
SVV-001 does not infect humans but propagates in tumor cells
showing neuroendocrine features. This property is being
exploited for developing SVV-001 as an oncolytic agent against
tumors such as small cell lung cancer (Reddy et al., 2007). The
virus is presently being studied extensively and characterized
by Neotropix under the trade name NTX-010.
This study describes the structure of SVV-001 and discusses
some of the receptors on cancer cells that the virus could poten-
tially bind to during its entry into the susceptible cells. In addition,
the characteristics of the bulk organization of packaged nucleic
acid visualized at 20A˚ resolution and its interactions with the
contiguous capsid shell of SVV-001 are also examined.
RESULTS AND DISCUSSION
Structure of SVV-001
The protomer of SVV-001 is composed of four different subunits,
VP1, VP2, VP3, and VP4, of lengths 263, 284, 239, and 72 resi-
dues, respectively. The overall folds of the subunits (Figure 1)
are very similar to the corresponding proteins in other viruses
from the Picornaviridae family. Similar to other cardioviruses
(Grant et al., 1992; Krishnaswamy and Rossmann, 1990; Luo
et al., 1987, 1992), VP1 of SVV-001 possesses a hydrophobic
pocket without a pocket factor. However, the entrance to the hy-
drophobic cleft in SVV-001 is almost completely sealed off by
residuesW140, F180, W184, D213, andW214 from the VP1 sub-
unit, whereas in the cardioviruses and rhinoviruses (Hadfield
et al., 1997; Kim et al., 1989; Verdaguer et al., 2000; Zhao
et al., 1996) the entrance is narrow and wide, respectively.
The reasons for the variant cell tropism of picornaviruses are
owing to the composition, location, length, and disposition of
surface-exposed loops of the capsid proteins, which are typical
of individual viruses in Picornaviridae (Rossmann et al., 1985). In
SVV-001, BC loop (residues 48–72), loop II (CD loop, residues
92–107), and FMDV loop (GH loop, residues 183–213) of VP1,
the ‘‘puff’’ (EF loop, residues 170–198) of VP2, and the ‘‘knob’’
(residues 55–71) of the VP3 subunit are of particular importance
(Figure 1) as they are more prominent in length when compared
with other members of Picornaviridae (Filman et al., 1998; Fry1561, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1555
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Structure of Seneca Valley Virus-001Figure 1. Protomer Structure and the Quality of the Electron Density Map of SVV-001
(A and B) Ribbon diagrams of SVV-001 protomer, (A) front view and (B) a side view, highlighting the different subunits and the prominent surface loops. VP1, VP2,
VP3, and VP4 subunits are shown in blue, green, red, and yellow, respectively.
(C) Stereo diagram showing the quality of the NCS-averaged electron density map at 2.3 A˚ resolution of residues 115–120 in the VP1 subunit, contoured at 1.2s.1556 Structure 16, 1555–1561, October 8, 2008 ª2008 Elsevier Ltd All rights reserved
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Structure of Seneca Valley Virus-001et al., 2003; Grant et al., 1992; Hadfield et al., 1997; Hogle et al.,
1985; Kim et al., 1989; Krishnaswamy and Rossmann, 1990;
Logan et al., 1993; Luo et al., 1992; Muckelbauer et al., 1995;
Rossmann et al., 1985). On the contrary, loop I (CD loop, resi-
dues 80–85 of VP1) in SVV-001 is shorter and concealed by
the loops BC and II of VP1. Apart from the knob of VP3 subunit,
the other loops of SVV-001 are structurally well ordered.
The capsid of SVV-001 has a maximum diameter of 325 A˚ with
a contiguous shell thickness of 25 A˚ and surface unevenness
(Figure 2A). The highest elevation (325 A˚ in diameter) occurs
close to the fivefold axis and is formed by the stacking of three
loops, two from VP1 (loops BC and II) and the third from VP2
(the puff). The knob of VP3 stands alone closest to the threefold
axis. The accessible surface area of the residues of the various
loops of the three subunits, as calculated using VIPERdb (Shep-
herd et al., 2006), suggests that the loops II of VP1 and the knob
of VP3 have the highest effective solvent-accessible surface
area (SASA) of 7000 A˚2. The puff of the VP2 subunit has an ef-
fective SASA of6000 A˚2. As opposed to members of the rhino-
virus family that display more prominent VP2 loops and smaller
VP1 loops, members of cardiovirus have prominent loops of
both VP1 and VP2. However, the lengths and disposition of these
loops in SVV-001 and the other cardioviruses leads to varied sur-
face features and the filling up of the canyon. Instead of the can-
yon, SVV-001 and the members of Cardioviridae (Figure 2B)
show a sharp pit.
Analysis of the RMSDs of the main chain Ca atoms of the pro-
tomer of SVV-001with other representativemembers ofPicorna-
viridae shows a maximum (1.4 A˚, number of aligned residues
Figure 2. Structural Comparison of SVV-001
and MEV Capsids
Surface-rendered illustrations of (A) SVV-001 and
(B) MEV capsid highlighting the differences of their
surfaces, generated using the program TexMol
(Bajaj et al., 2004). A coloring scheme of blue to
yellow was used as a function of the distance
from the center of the virus. The blue regions rep-
resent the depressions; the yellow regions repre-
sent the elevations on the surface. Ribbon dia-
grams of the superposition of (C) VP1, (D) VP2,
and (E) VP3 subunits of MEV (magenta) onto the
corresponding subunits of SVV-001 (blue). Corre-
sponding loops showing maximum structural dif-
ferences are highlighted by arrows.
500) and minimum (1.2 A˚, number of
aligned residues 600) deviation with
the members of rhinovirus (Hadfield
et al., 1997; Kim et al., 1989; Verdaguer
et al., 2000; Zhao et al., 1996) and cardi-
ovirus (Grant et al., 1992; Krishnaswamy
and Rossmann, 1990; Luo et al., 1992),
respectively. In accordance with the
structural similarity, SVV-001 shows
maximum (42%) and minimum (30%)
sequence identity with mengo encepha-
lomyocarditis virus (MEV) and human rhi-
novirus (HRV) 16, respectively. Figures
2C–E show the superposition of the subunits of MEV onto corre-
sponding subunits of SVV-001. Individually, the VP1 and VP2
subunits of SVV-001 show maximum and minimum structural
variation, respectively, with the othermembers of Picornaviridae.
Nucleic Acid Arrangement
A low-resolution (20 A˚) map of SVV-001 showed the arrange-
ment of nucleic acid inside the capsid shell, visualized using
X-ray crystallography for the first time for any picornavirus. The
bulk nucleic acid organization in SVV-001 seems to be continu-
ously in contact with the inner surface of the capsid, with more
prominent contacts near the icosahedral twofold axes beneath
two VP2 subunits (Figure 3). There is an innermost compact
sphere of density at the center of the viral capsid surrounded
by a few discontinuous isolated densities. Closest to the capsid
layer is amore continuous shell of RNA density that interacts with
residues 41–43, 55–57 of VP2 and 63, 64 of VP4 subunits and
could potentially play a role as a scaffold for capsid assembly
and architecture. It is possible that similar nucleic acid organiza-
tion may also be present in other picornaviruses.
Putative Receptors of SVV-001
Though there are receptors known for many picornaviruses
(Rossmann et al., 2002), receptor(s) for Senecaviruses are yet
to be determined. Because SVV-001 is known to target cells
with neuroendocrine tumor features, it is possible that the cell
tropism of SVV-001 might be governed by binding to receptors
expressed on such tumor cells. A few that have been suggested
include markers such as gastrin-releasing peptide receptors,
Structure 16, 1555–1561, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1557
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Structure of Seneca Valley Virus-001synaptophysin, neuron-specific enolase, and CD56 (Wadhwa
et al., 2007). However, no structural evidence could be estab-
lished for the binding of SVV-001 to any of these receptors. Nev-
ertheless, the outer capsid features of SVV-001 were analyzed to
gain insights into other possible receptors to which it might bind
(Figures 4A and 4B). Of these were the av integrins, which are
recognized by the arginine-glycine-aspartic acid (RGD) motif in
Figure 3. An Illustration of Nucleic Acid Organization in SVV-001
at 20 A˚ Resolution
(A) A view down the particle twofold axis showing the bulk RNA density (or-
ange) and part of the protein shell.
(B) A side view of the same.1558 Structure 16, 1555–1561, October 8, 2008 ª2008 Elsevier Ltdfoot-and-mouth disease virus (FMDV) (Logan et al., 1993). It is
known that the lysine-glycine-aspartic acid (KGD) motif mimics
RGD in many cases (Reiss et al., 2006; Lu et al., 2006). Although
themotif KGDdoes not occur on the surface of SVV-001 capsids,
its reverse motif, DGK (residues 146–148), is found in the VP2
subunit of SVV-001. The main chain conformation of RGD bound
to integrinmolecule in aRGD-integrin complex (Xiong et al., 2002)
matches well with the main chain conformation of the DGKmotif
of SVV-001 (Figure 4C). Furthermore, the DGK motif is exposed
on the surface of SVV-001 and is located in the canyon formed
by the VP1/2 loops and the puff of VP2. So it is likely that the
DGKmotif might play an important role in recognizing integrin re-
ceptors on the cell surfaces. In addition to theDGKmotif, another
integrin bindingmotif, LDV (residues 141–143 of VP2), also exists
on the surface of SVV-001 capsids. This motif is known to bind to
specific a1b4 integrins expressed on small-cell lung cancer cells
(Tselepis et al., 1997). However, the LDV motif is not exposed
on the surface and lies in a depression that is immediately next
to the puff of VP2 subunit and is less accessible (Figure 4D). How-
ever, it is possible that local conformational changes could
expose this motif and aid in receptor binding. Because DGK
and LDV motifs are structurally proximal (Figure 4B), they could
be jointly involved in binding to integrins on the cell surface.
Another receptor that SVV-001 could bind to is low-density li-
poprotein receptor (LDLR). Essentially the N-terminal extracellu-
lar region of LDLR is the one that is recognized by viruses. The
structure of HRV2 complexed with a fragment of LDLR (Verda-
guer et al., 2004) suggests that three residues interact with the
receptor, of which K224 of VP1 is most crucial and conserved
in all minor group members (e.g., HRV1a). The structural super-
position of SVV-001 onto HRV2-LDLR showed that a highly ex-
posed lysine (K227) of VP1 in SVV-001 nearly overlaps with the
conserved lysine K224 of HRV2, which is known to be involved
in crucial interactions with the LDLR. Except for this lysine, the
other proximal residues are variable among the members of
minor group rhinoviruses that bind to the LDLR. The K227 of
SVV-001 is exposedwith an effective SASA of 4500 A˚2 and could
play a role in binding to LDLR, suggesting that the LDLR is an-
other plausible receptor for SVV-001 (Figure 4E).
Additionally, structural comparison of SVV-001 with MEV
(Krishnaswamy and Rossmann, 1990; Luo et al., 1987) shows
that there is no corresponding lysine for K227 in the MEV struc-
ture. The loop (HI), which harbors K227 in SVV-001, is much
shorter in MEV and takes a different path. Although the SVV-
001 structure is closest to MEV, it resembles rather well locally
with the LDL-binding region of HRV2. However, the LDV motif
seen in SVV-001 is also present in MEV, but absent in HRV2.
TheLDVmotif inMEV is surface accessible; however, the involve-
ment of this motif in receptor binding has not been investigated
for MEV. The DGK motif seen in SVV-001 is not present in MEV.
EXPERIMENTAL PROCEDURES
The SVV-001 was crystallized in a R3 space group with unit cell dimensions
a = b = 311.5 A˚, c = 1526.4 A˚, a = b = 90, g = 120, and its structure was de-
termined at 2.3 A˚ resolution by molecular replacement using MEV capsid as
the model (Venkataraman et al., 2008). The unit cell of SVV-001 is unusual be-
cause of a long c axis (1526 A˚) that is nearly 4.9 times the lengths of a or b axis
(311 A˚) and hence accommodates six virus particles. Two sets of 20mers con-
tributed by two distinct virus particles located at (0, 0, 0) and (0.333, 0.666,All rights reserved
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Structure of Seneca Valley Virus-001Figure 4. Locations of Putative Receptor
Binding Sites on SVV-001
(A) Positions of major receptor binding motifs on
the surface of SVV-001. Sites 1 and 2 indicate
the locations of the DGK and the LDV motif;
K227 is site 3. The LDV motif (site 2) is hidden un-
der the DGKmotif (site 1) and is indicated by an ar-
row. The icosahedral asymmetric unit comprising
VP1-4 is indicated by a trapezoid.
(B) Enlarged view of the icosahedral asymmetric
unit oriented to highlight the positions of DGK,
LDV, and K227.
(C) The superposition of DGK motif (gold) on the
RGD motif (cyan).
(D) Location of the LDVmotif, shown as purple sur-
face and stick diagram, in the VP2 subunit.
(E) Structural superposition of loop containing
K227 (VP1) of SVV-001 (pink) onto LDL binding
loop of HRV2. The structural proximity of K227 of
SVV-001 with the critical residue, K224 of HRV2
in the HRV2-LDL receptor (baize-colored surface)
complex, indicates that it might play a similar role
in binding to the LDL receptor in SVV-001.
0.166) occupy the crystallographic asymmetric
unit. The orientation of the two distinct particles
was determined using the program GLRF (Tong
and Rossmann, 1990), and the particle positions
were determined using the program Phaser
(Read, 2001; Storoni et al., 2004). The initial phase
extension and NCS averaging using RAVE (Kley-
wegt and Jones, 1994) and CCP4 suite of pro-
grams (CCP4, 1994) resulted in readily interpret-
able maps at 2.3 A˚ with a final real-space R factor
of 0.23 and correlation coefficient of 0.93.
The final model was built manually into the elec-
tron density map contoured at 1.2s using the pro-
gram O (Jones et al., 1991). The structure was refined using the program CNS
(Brunger et al., 1998) imposing (strict) 40-fold noncrystallographic symmetry
(NCS) constraints. Water molecules were picked initially using the program
CNS and later manually from once averaged Fo-Fc map contoured at 2.5s.
A low-resolution (100–20 A˚) vector differencemap was calculated by subtract-
ing model amplitude and phases from the Fobs and phase-refined phases to
visualize the bulk nucleic acid density. The final refinement statistics are shown
in Table 1.
Model quality was analyzed using PROCHECK (Laskowski et al., 1993), and
Stride (Heinig and Frishman, 2004) was used for the assignment of secondary
structures. TOP3d from CCP4 suite of programs and ALIGN (Cohen, 1997)
were used for structure alignment. PyMOL (http://www.pymol.org), Chimera
(Pettersen et al., 2004), and VMD (Humphrey et al., 1996) were used for struc-
ture visualization, analysis, and generation of figures. VIPERdb analysis (Shep-
herd et al., 2006) was employed to estimate buried and accessible surface
areas and association energies. Intra/intersubunit contacts, average B, and in-
dividual accessible surface area were calculated using CCP4 suite of pro-
grams (CCP4, 1994).
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